Jeanette M. Bouma

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)

Koen P. Rovers, Checca Bakkers, Geert A. Simkens et al. · BMC Cancer · 2019 · 111 citations · Full text

Medicine, Oncology, Surgery +14

Effects of interleukin-3 after chemotherapy for advanced ovarian cancer

Bonne Biesma, PH Willemse, NH Mulder et al. · Blood · 1992 · 87 citations · Full text

Medicine, Immunology, Oncology +12

Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases

Koen P. Rovers, Checca Bakkers, Simon W. Nienhuijs et al. · JAMA Surgery · 2021 · 73 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial

Cathalijne Post, Stephanie M. de Boer, Melanie Powell et al. · The Lancet Oncology · 2025 · 29 citations · Full text

Medicine, Gynecology, Oncology +17

Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)

Anouk K. M. Claessens, Monique E.M.M. Bos, Marta López‐Yurda et al. · Breast Cancer Research and Treatment · 2018 · 17 citations

Medicine, Oncology, Pharmacotherapy +16